These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30896644)

  • 21. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy.
    Ufer M; von Stülpnagel C; Muhle H; Haenisch S; Remmler C; Majed A; Plischke H; Stephani U; Kluger G; Cascorbi I
    Pharmacogenet Genomics; 2011 Oct; 21(10):624-30. PubMed ID: 21799461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population.
    Zhou L; Cao Y; Long H; Long L; Xu L; Liu Z; Zhang Y; Xiao B
    Pharmazie; 2015 Jun; 70(6):416-20. PubMed ID: 26189305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy.
    Sattler A; Schaefer M; May TW
    Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers.
    Antunes NJ; Wichert-Ana L; Coelho EB; Della Pasqua O; Alexandre Junior V; Takayanagui OM; Marques MP; Lanchote VL
    J Pharm Biomed Anal; 2018 Feb; 149():442-447. PubMed ID: 29169112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD).
    Miles MV; Tang PH; Ryan MA; Grim SA; Fakhoury TA; Strawsburg RH; DeGrauw TJ; Baumann RJ
    Ther Drug Monit; 2004 Jun; 26(3):300-4. PubMed ID: 15167632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine.
    Flesch G; Czendlik C; Renard D; Lloyd P
    Drug Metab Dispos; 2011 Jun; 39(6):1103-10. PubMed ID: 21389120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers.
    Antunes Nde J; Wichert-Ana L; Coelho EB; Della Pasqua O; Alexandre Junior V; Takayanagui OM; Tozatto E; Marques MP; Lanchote VL
    Eur J Clin Pharmacol; 2016 Feb; 72(2):195-201. PubMed ID: 26514967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
    Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
    Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy.
    Yu Y; Zhang Q; Xu W; Lv C; Hao G
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):345-51. PubMed ID: 25700977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetics modeling of oxcarbazepine to characterize drug interactions in Chinese children with epilepsy.
    Wang Y; Zhang HN; Niu CH; Gao P; Chen YJ; Peng J; Liu MC; Xu H
    Acta Pharmacol Sin; 2014 Oct; 35(10):1342-50. PubMed ID: 25220641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium.
    Mazzucchelli I; Onat FY; Ozkara C; Atakli D; Specchio LM; Neve AL; Gatti G; Perucca E
    Epilepsia; 2006 Mar; 47(3):504-9. PubMed ID: 16529613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics of oxcarbazepine in the treatment of epilepsy.
    Yuan Y; Zhang S; Yuan Y; Yan X; Zhang L; Ran YW
    Pharmacogenomics; 2023 Apr; 24(6):335-343. PubMed ID: 37092337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telmisartan pharmacokinetics in Japanese renal transplant recipients.
    Miura M; Satoh S; Inoue K; Saito M; Habuchi T; Suzuki T
    Clin Chim Acta; 2009 Jan; 399(1-2):83-7. PubMed ID: 18838068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy.
    Jang Y; Yoon S; Kim TJ; Lee S; Yu KS; Jang IJ; Chu K; Lee SK
    Sci Rep; 2021 Mar; 11(1):6370. PubMed ID: 33737678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
    McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy.
    Maschio M; Albani F; Jandolo B; Zarabla A; Contin M; Dinapoli L; Fabi A; Pace A; Baruzzi A
    J Neurooncol; 2008 Nov; 90(2):217-21. PubMed ID: 18612799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABCC2 rs2273697 is associated with valproic acid concentrations in patients with epilepsy on valproic acid monotherapy.
    Chen J; Su QB; Tao YQ; Qin JM; Zhou Y; Zhou S; Li HL; Chen ZJ; Zhou YF; Zhou LM; Wang XD; Huang M
    Pharmazie; 2018 May; 73(5):279-282. PubMed ID: 29724294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric patients with epilepsy: Model-based dose optimization.
    Wu W; Yang WS; Xu XY; Ge XL; Lu J; Wang GF; Wang Y; Li ZP
    Basic Clin Pharmacol Toxicol; 2024 May; 134(5):712-726. PubMed ID: 38506371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of SCN1Aand SCN2A gene polymorphisms on the efficacy of valproic acid treatment in Chinese children with epilepsy.
    Bao Z; Li H; Hu J; Zhao R; Yan L; Zheng A
    PLoS One; 2024; 19(6):e0304869. PubMed ID: 38837984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy.
    Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY
    Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.